Amphetamines are likely to become increasingly abused, due In part to the recent introduction of 'Ice', an inexpensive smokeable methamphetamine. Clinical approaches to amphetamine abuse have long been frustrated by a lack of understanding of Its mechanism of action, which apparently differs from that of cocaine. Although both produce psychostimulant and rewarding effects by increasing extraneuronal dopamine, cocaine acts by inhibiting the dopamine uptake transporter, while amphetamine both reduces uptake and increases dopamine release from intracellular stores. Since the fundamental actions of amphetamine and cocaine are apparently quite different, It is probable that clinical treatments for amphetamine abuse will require different approaches. Two recent advances may elucidate the action of amphetamine and related psychostimulants: 1) a novel mechanism (the weak base hypothesis) has been discovered which appears to explain the primary molecular basis for amphetamine effects, and 2) the development of an in vitro culture preparation using dissociated, Identified mesoaccumbens dopamine neurons now allows direct study of the cellular substrate for the rewarding effects of amphetamine and cocaine. Using these advances will further understanding of the mechanism of action amphetamine-like psychostimulants. Immunocytochemical, electron microscopic, biochemical techniques will be used to quantify the direct effects of amphetamine vesicle alkalinization and on uptake and release of neurotransmitter from synaptic cells. Electrophysiological analysis of cultured mesoaccumbens synapses promises to be useful for the study of amphetamine's pre- and post-synaptic effects In the pharmacologically appropriate neural circuit and for study of the roles of the presynaptic classical transmitter (dopamine) and the peptide cotransmitter (CCK8-S) in the reward pathway. The weak base model also suggests several important predictions, Including; 1) amphetamine should increase extracellular catecholamine, but not peptide cotransmitters; 2) psychostimulants could lead to changes In Ionic gradients that could help explain stimulant-- induced neurotoxicity; 3) changes in the pH gradient of synaptic vesicles should be an useful In vitro method to predict the behavioral efficacy of amphetamine-like stimulant drugs; and 4) animals should self-administer intracerebral injection of weak base drugs that do not normally cross the blood/brain barrier.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29DA007418-01
Application #
3461319
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1991-07-01
Project End
1996-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Pereira, Daniela B; Schmitz, Yvonne; Mészáros, József et al. (2016) Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum. Nat Neurosci 19:578-86
Wong, M Y; Borgkvist, A; Choi, S J et al. (2015) Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior. Neuroscience 290:594-607
Mrejeru, A; Martí-Prats, L; Avegno, E M et al. (2015) A subset of ventral tegmental area dopamine neurons responds to acute ethanol. Neuroscience 290:649-58
Karpowicz Jr, Richard J; Dunn, Matthew; Sulzer, David et al. (2013) APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter. ACS Chem Neurosci 4:858-69
Sames, Dalibor; Dunn, Matthew; Karpowicz Jr, Richard J et al. (2013) Visualizing neurotransmitter secretion at individual synapses. ACS Chem Neurosci 4:648-51
Hu, Gang; Henke, Adam; Karpowicz Jr, Richard J et al. (2013) New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2). ACS Chem Biol 8:1947-54
Hernandez, Daniela; Torres, Ciara A; Setlik, Wanda et al. (2012) Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74:277-84
Wong, Minerva Y; Sulzer, David; Bamford, Nigel S (2011) Imaging presynaptic exocytosis in corticostriatal slices. Methods Mol Biol 793:363-76
Lyon, Gholson J; Abi-Dargham, Anissa; Moore, Holly et al. (2011) Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull 37:108-17